OraSure Technologies, Inc. (OSUR)
NASDAQ: OSUR · Real-Time Price · USD
3.430
-0.060 (-1.72%)
At close: Mar 28, 2025, 4:00 PM
3.485
+0.055 (1.59%)
After-hours: Mar 28, 2025, 7:50 PM EDT
OraSure Technologies Revenue
In the year 2024, OraSure Technologies had annual revenue of $185.83M, down -54.17%. OraSure Technologies had revenue of $37.45M in the quarter ending December 31, 2024, a decrease of -50.65%.
Revenue (ttm)
$185.83M
Revenue Growth
-54.17%
P/S Ratio
1.40
Revenue / Employee
$370,912
Employees
501
Market Cap
256.56M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 185.83M | -219.65M | -54.17% |
Dec 31, 2023 | 405.47M | 17.99M | 4.64% |
Dec 31, 2022 | 387.48M | 153.81M | 65.82% |
Dec 31, 2021 | 233.67M | 61.95M | 36.08% |
Dec 31, 2020 | 171.72M | 17.12M | 11.07% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 400.28B |
Johnson & Johnson | 88.82B |
Merck & Co. | 64.17B |
AbbVie | 56.33B |
AstraZeneca | 54.07B |
Novartis AG | 51.72B |
Eli Lilly and Company | 45.04B |
Thermo Fisher Scientific | 42.88B |
OSUR News
- 4 days ago - OraSure Announces $40 Million Stock Repurchase Program - GlobeNewsWire
- 4 weeks ago - OraSure Technologies, Inc. (OSUR) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 6 weeks ago - OraSure to Announce Fourth Quarter 2024 Financial Results and Host Earnings Call on February 25th - GlobeNewsWire
- 2 months ago - NOWDiagnostics Responds with Countersuit Against Frivolous OraSure Claims - Business Wire
- 2 months ago - OraSure to Present at the J.P Morgan Healthcare Conference - GlobeNewsWire
- 2 months ago - CORRECTION - OraQuick® HIV Self-Test Now Approved for Use in Adolescents - GlobeNewsWire
- 2 months ago - OraQuick® HIV Self-Test Now Approved for Use in Adolescents - GlobeNewsWire
- 3 months ago - OraSure Technologies Acquires Sherlock Biosciences - GlobeNewsWire